Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hodgkin Disease 6Lymphoma 3Lymphoma, T-Cell, Cutaneous 2Hematologic Diseases 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Primary Cutaneous Anaplastic Large Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 5Vincristine 4Prednisolone 3Methotrexate 3Doxorubicin 3Cytarabine 3pegfilgrastim 2Radiotherapy 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Early Intervention, Educational 2liposomal amphotericin B 1glutamic acid diethyl ester 1aldesleukin 1Vancomycin 1Valacyclovir 1Thioguanine 1Therapeutics 1Tazobactam 1Rituximab 1Ribavirin 1Psychiatric Rehabilitation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Palivizumab 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Dendritic Cell Sarcoma, Interdigitating × Brentuximab Vedotin × Clear all
NCT06186986 2024-01-02

CD30 Imaging in Diffuse Large B-cell Lymphoma

University Medical Center Groningen

Phase 3 Unknown
20 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡